Does hepatitis C virus infection increase risk for stroke? A population-based cohort study

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Liao, Chien Chang ^a,b   Su, Ta Chen ^c   Sung, Fung Chang ^d   Chou, Wan Hsin ^a,b   Chen, Ta Liang ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; GENERAL ASPECTS OF DISEASE; HEALTH INSURANCE; HEART DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDY; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; RISK ASSESSMENT; SEX; SMOKING CESSATION; TAIWAN; URBANIZATION; CONFIDENCE INTERVAL; DEMOGRAPHY; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STROKE; VIROLOGY;

ADULT; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; DEMOGRAPHY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; TAIWAN; YOUNG ADULT;

EID: 84857438321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031527     Document Type: Article

References (26)

1. Lauer GM, Walker BD, (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52.
2. Flamm SL, (2003) Chronic hepatitis C virus infection. JAMA 289: 2413-2417.
3. Feigin VL, (2007) Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol 6: 94-97.
4. Strong K, Mathers C, Bonita R, (2007) Preventing stroke: saving lives around the world. Lancet Neurol 6: 182-187.
5. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123.
6. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, et al. (2010) Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 47: 72-75.
7. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, et al. (2002) Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359: 133-135.
8. Aslam F, Alam M, Lakkis NM, (2010) Hepatitis C and carotid atherosclerosis: a retrospective analysis. Atherosclerosis 209: 340-343.
9. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T, (2003) Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 289: 1245-1246.
10. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, et al. (2001) Evidence for a cerebral effect of the hepatitis C virus. Lancet 358: 38-39.
11. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, et al. (2010) Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 41: 2894-2900.
12. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML, (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20: 236-242.
13. Bilora F, Campagnolo E, Rinaldi R, Rossato A, Arzenton M, et al. (2009) Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up. Angiology 59: 717-720.
14. Völzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, et al. (2004) Hepatitis B and C virus infections and the risk of atherosclerosis in a general population. Atherosclerosis 174: 99-103.
15. Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA, (2006) No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 43: e53-e56.
16. Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, et al. (2007) The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS 21: 193-197.
17. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, et al. (2010) Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med 11: 462-468.
18. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, et al. (2003) Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 67: 26-30.
19. Oyake N, Shimada T, Murakami Y, Ishibashi Y, Satoh H, et al. (2008) Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients. J Nephrol 21: 345-353.
20. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, et al. (2001) Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103: 1064-1070.
21. Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, et al. (2003) Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 98: 2064-2071.
22. White DL, Ratziu V, El-Serag HB, (2008) Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 49: 831-844.
23. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ, (2008) Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology 47: 2127-2133.
24. Rouabhia S, Malek R, Bounecer H, Dekaken A, Bendali Amor F, et al. (2010) Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol 16: 3427-3431.
25. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, et al. (2011) Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke 42: 1314-1319.
26. Shah NR, Ogedegbe G, (2010) ACP Journal Club. Review: first-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension. Ann Intern Med 152: JC1-4.